Noopept CAS#157115-85-0
Defined Pharmaceutical Applications – N-(1-(Phenylacetyl)-L-prolyl)glycine Ethyl Ester is marketed under the trade name NOOPEPT and has applications in pharmaceutical treatment.
Obesity-Related Applications – The compound is used in connection with the treatment of obesity, providing a specialized application in weight-related pharmaceutical fields.
Alcohol Dependence Support – It is also used for the treatment of alcohol dependence, highlighting its potential application in related therapeutic areas.
Applications in Degenerative and Toxic Conditions – N-(1-(Phenylacetyl)-L-prolyl)glycine Ethyl Ester is used in the treatment of degeneration and toxic injuries, offering broader pharmaceutical applications.
Products Description of Noopept CAS#157115-85-0
N-(1-(Phenylacetyl)-L-prolyl)glycine ethyl ester, marketed under the trade name NOOPEPT, is a compound used in the treatment of obesity, alcohol dependence, degenerative conditions, and toxic injuries.
Noopept Chemical Properties
| Melting point | 94.0 to 98.0 °C |
| Boiling point | 547.3±50.0 °C(Predicted) |
| density | 1.202±0.06 g/cm3(Predicted) |
| storage temp. | -20°C |
| solubility | Soluble in DMSO (up to 25 mg/ml) |
| form | powder |
| pka | 13.41±0.20(Predicted) |
| color | white to beige |
| optical activity | [α]/D -115 to -125°, c = 0.5 in chloroform-d |
| Stability: | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months. |
| InChI | InChI=1S/C17H22N2O4/c1-2-23-16(21)12-18-17(22)14-9-6-10-19(14)15(20)11-13-7-4-3-5-8-13/h3-5,7-8,14H,2,6,9-12H2,1H3,(H,18,22)/t14-/m0/s1 |
| InChIKey | PJNSMUBMSNAEEN-AWEZNQCLSA-N |
| SMILES | C(OCC)(=O)CNC(=O)[C@@H]1CCCN1C(CC1=CC=CC=C1)=O |
| CAS DataBase Reference | 157115-85-0 |
| RTECS | MC0814400 |
| HS Code | 29339900 |
